• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用特比萘芬乳胶凝胶对足癣进行短期局部治疗:一项剂量范围临床试验的结果

Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.

作者信息

James Ian G, Loria-Kanza Yolanda, Jones Thomas C

机构信息

Spring House Surgery, Bolton, United Kingdom.

出版信息

J Dermatolog Treat. 2007;18(3):163-8. doi: 10.1080/09546630701247971.

DOI:10.1080/09546630701247971
PMID:17538805
Abstract

BACKGROUND

In the treatment of tinea pedis, current terbinafine formulations are applied once or twice daily for 7 days. A terbinafine emulsion gel formulation has been developed to provide a 5-day treatment course for tinea pedis.

OBJECTIVE

To determine the lowest effective concentration of terbinafine (1% or 3%) emulsion gel applied once daily for 5 days for the treatment of tinea pedis.

METHODS

This double-blind, placebo-controlled study evaluated the efficacy of 1% and 3% terbinafine gel for 5 days in 84 outpatients with tinea pedis. The primary efficacy endpoint was the percentage of patients with effective treatment (negative microscopy and culture with only mild erythema/desquamation/pruritus [total score<or=2]) at study endpoint (last post-baseline observation up to and including week 6).

RESULTS

Efficacy rates with terbinafine 1% and 3% emulsion gel were significantly higher than with placebo (86% and 68% vs 11%, respectively; p<0.001). Similarly, mycological cure rates were significantly greater with terbinafine 1% and 3% gel (97% and 89%, respectively) than with placebo (22%; p<0.001).

CONCLUSIONS

Terbinafine 1% emulsion gel used once daily for 5 days was the lowest effective concentration, and was significantly superior to placebo. Both concentrations were effective and safe, providing convenient, short-duration treatment of tinea pedis.

摘要

背景

在足癣治疗中,目前的特比萘芬制剂每日应用1次或2次,疗程为7天。已研发出一种特比萘芬乳胶凝胶制剂,用于足癣的5天治疗疗程。

目的

确定每日应用1次、疗程为5天的特比萘芬(1%或3%)乳胶凝胶治疗足癣的最低有效浓度。

方法

这项双盲、安慰剂对照研究评估了84例足癣门诊患者使用1%和3%特比萘芬凝胶5天的疗效。主要疗效终点是在研究终点(基线后最后一次观察直至并包括第6周)时治疗有效的患者百分比(显微镜检查和培养阴性,仅有轻度红斑/脱屑/瘙痒[总分≤2分])。

结果

1%和3%特比萘芬乳胶凝胶的有效率显著高于安慰剂(分别为86%和68% 对11%;p<0.001)。同样,1%和3%特比萘芬凝胶的真菌学治愈率(分别为97%和89%)显著高于安慰剂(22%;p<0.001)。

结论

每日应用1次、疗程为5天的1%特比萘芬乳胶凝胶是最低有效浓度,且显著优于安慰剂。两种浓度均有效且安全,为足癣提供了方便的短疗程治疗。

相似文献

1
Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.使用特比萘芬乳胶凝胶对足癣进行短期局部治疗:一项剂量范围临床试验的结果
J Dermatolog Treat. 2007;18(3):163-8. doi: 10.1080/09546630701247971.
2
Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.无论治疗方案如何,特比萘芬各种外用制剂治疗足癣的疗效和安全性相当:一项荟萃分析的结果
Am J Clin Dermatol. 2007;8(6):357-64. doi: 10.2165/00128071-200708060-00005.
3
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.一种新型单剂量1%特比萘芬制剂治疗足癣(运动员脚癣)患者的疗效与安全性:一项随机、双盲、安慰剂对照研究。
J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1307-13. doi: 10.1111/j.1468-3083.2006.01807.x.
4
Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.每日一次外用1%特比萘芬乳膏(兰美抒),持续一周,对体癣和股癣治疗有效。一项安慰剂对照研究。
Mycoses. 2001;44(7-8):300-6.
5
Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.2%盐酸萘替芬凝胶:治疗足跟型足癣的有效局部用药
J Drugs Dermatol. 2015 Oct;14(10):1138-44.
6
Tinea pedis: clinical experience and efficacy of short treatment.足癣:短期治疗的临床经验与疗效
Dermatology. 1997;194 Suppl 1:3-6. doi: 10.1159/000246173.
7
Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.1%特比萘芬溶液治疗足趾间足癣及体癣或股癣的疗效与安全性。
Cutis. 2001 Mar;67(3):261-6.
8
Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial.使用特比萘芬对足癣进行新型单剂量局部治疗:剂量探索性临床试验结果
Mycoses. 2008 Jan;51(1):1-6. doi: 10.1111/j.1439-0507.2007.01429.x.
9
Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.特比萘芬局部喷雾与特比萘芬局部溶液的疗效、耐受性和消费者可接受性:一项 IIa 期、随机、观察者盲、对照研究。
Am J Clin Dermatol. 2013 Oct;14(5):413-9. doi: 10.1007/s40257-013-0031-y.
10
One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.为期一周每天一次外用1%特比萘芬乳膏(兰美抒)治疗足趾间足癣有效:一项赋形剂对照研究。LAS-INT-06研究组。
Med Mycol. 2001 Aug;39(4):335-40. doi: 10.1080/mmy.39.4.335.340.

引用本文的文献

1
Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis.用于递送DNDI-0690治疗皮肤利什曼病的成膜系统
Pharmaceutics. 2021 Apr 8;13(4):516. doi: 10.3390/pharmaceutics13040516.
2
Athlete's foot.足癣
BMJ Clin Evid. 2009 Jul 20;2009:1712.
3
Update on terbinafine with a focus on dermatophytoses.特比萘芬更新:重点关注皮肤癣菌病。
Clin Cosmet Investig Dermatol. 2009 Apr 21;2:49-63. doi: 10.2147/ccid.s3690.
4
[Topical terbinafine. Reduction of duration of therapy for tinea pedis].[外用特比萘芬。减少足癣治疗疗程]
Hautarzt. 2008 Dec;59(12):986-91. doi: 10.1007/s00105-008-1552-9.